`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`Mylan Pharmaceuticals Inc., Petitioner
`
`v.
`
`Nissan Chemical Industries Ltd.
`Patent Owner
`
`U.S. Patent No. 5,856,336 to Fujikawa et al.
`Issue Date: January 5, 1999
`Title: Quinoline Type Mevalonolactones
`
`_____________________
`
`Inter Partes Review No.: IPR2015-01069
`
`MYLAN PHARMACEUTICALS INC.’S SUPPLEMENTAL EXHIBIT LIST
`
`Mail Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark
`Office P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`Exhibit
`
`1043
`
`1044
`
`Reference
`
`Declaration of Amy D. Brody in Support of Mylan
`Pharmaceuticals Inc’s Motion for Pro Hac Vice
`Admission
`
`Declaration of Thomas R. Burns in Support of Mylan
`Pharmaceuticals Inc’s Motion for Pro Hac Vice
`Admission
`
`2
`
`
`
`CERTIFICATE OF SERVICE
`I hereby certify that on this 21st day of August, 2015 a copy of this
`Supplemental Exhibit List is being served electronically (by consent of the Patent
`Owner) on the following e-mail addresses for counsel for Patent Owner:
`
`David G. Conlin (Reg. No. 27,026)
`(DGConlin@mintz.com)
`MINTZ LEVIN COHN FERRIS
`GLOVSKY AND POPEO, P.C.,
`One Financial Center
`Boston, Massachusetts 02111
`
`Kathleen B. Carr (Reg. No. 41,658)
`(KBCarr@mintz.com)
`MINTZ LEVIN COHN FERRIS GLOVSKY AND
`POPEO, P.C.
`One Financial Center
`Boston, Massachusetts 02111
`
`Respectfully submitted,
`
`ALSTON & BIRD LLP
`/ Jitendra Malik/
`Jitendra Malik, Reg. No. 55,823
`Attorney for Petitioner
`
`Date: August 21, 2015
`ALSTON & BIRD LLP
`4721 Emperor Blvd., Suite 400
`Durham, NC 27703
`
`3